- Home
- YMAT vs HOWL Comparison
YMAT vs HOWL Comparison
Compare YMAT & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAT
- HOWL
- Stock Information
- Founded
- YMAT 1970
- HOWL 2017
- Country
- YMAT Taiwan
- HOWL United States
- Employees
- YMAT N/A
- HOWL N/A
- Industry
- YMAT Recreational Games/Products/Toys
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- YMAT Consumer Discretionary
- HOWL Health Care
- Exchange
- YMAT Nasdaq
- HOWL Nasdaq
- Market Cap
- YMAT 76.4M
- HOWL 64.5M
- IPO Year
- YMAT 2025
- HOWL 2021
- Fundamental
- Price
- YMAT $1.42
- HOWL $1.43
- Analyst Decision
- YMAT
- HOWL Strong Buy
- Analyst Count
- YMAT 0
- HOWL 5
- Target Price
- YMAT N/A
- HOWL $7.20
- AVG Volume (30 Days)
- YMAT 735.7K
- HOWL 154.2K
- Earning Date
- YMAT 01-01-0001
- HOWL 11-06-2025
- Dividend Yield
- YMAT N/A
- HOWL N/A
- EPS Growth
- YMAT N/A
- HOWL N/A
- EPS
- YMAT 0.07
- HOWL N/A
- Revenue
- YMAT $17,563,985.00
- HOWL N/A
- Revenue This Year
- YMAT N/A
- HOWL N/A
- Revenue Next Year
- YMAT N/A
- HOWL N/A
- P/E Ratio
- YMAT $20.27
- HOWL N/A
- Revenue Growth
- YMAT N/A
- HOWL N/A
- 52 Week Low
- YMAT $1.15
- HOWL $0.60
- 52 Week High
- YMAT $6.45
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- YMAT N/A
- HOWL 61.71
- Support Level
- YMAT N/A
- HOWL $1.29
- Resistance Level
- YMAT N/A
- HOWL $1.49
- Average True Range (ATR)
- YMAT 0.00
- HOWL 0.07
- MACD
- YMAT 0.00
- HOWL 0.01
- Stochastic Oscillator
- YMAT 0.00
- HOWL 70.00
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.